Found: 50
Select item for more details and to access through your institution.
Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastoma.
- Published in:
- Cancer Communications, 2023, v. 43, n. 12, p. 1326, doi. 10.1002/cac2.12502
- By:
- Publication type:
- Article
Inhibition of tumor growth by ERK1/2 inhibitors is associated with the induction of interferon‐γ production (397.3).
- Published in:
- FASEB Journal, 2014, v. 28, p. N.PAG, doi. 10.1096/fasebj.28.1_supplement.397.3
- By:
- Publication type:
- Article
Identification of FOXM1 as a specific marker for triple-negative breast cancer.
- Published in:
- International Journal of Oncology, 2019, v. 54, n. 1, p. 87, doi. 10.3892/ijo.2018.4598
- By:
- Publication type:
- Article
HOTAIR upregulates an 18-gene cell cycle-related mRNA network in glioma.
- Published in:
- International Journal of Oncology, 2017, v. 50, n. 4, p. 1271, doi. 10.3892/ijo.2017.3901
- By:
- Publication type:
- Article
UBE2C induces EMT through Wnt/ß-catenin and PI3K/Akt signaling pathways by regulating phosphorylation levels of Aurora-A.
- Published in:
- International Journal of Oncology, 2017, v. 50, n. 4, p. 1116, doi. 10.3892/ijo.2017.3880
- By:
- Publication type:
- Article
Investigation of Gynura segetum root extract (GSrE) induced hepatotoxicity based on metabolomic signatures and microbial community profiling in rats.
- Published in:
- Frontiers in Microbiology, 2022, v. 13, p. 1, doi. 10.3389/fmicb.2022.947757
- By:
- Publication type:
- Article
The Role of Gut Microbiota-Bile Acids Axis in the Progression of Non-alcoholic Fatty Liver Disease.
- Published in:
- Frontiers in Microbiology, 2022, v. 13, p. 1, doi. 10.3389/fmicb.2022.908011
- By:
- Publication type:
- Article
The Impact of Instant Coffee and Decaffeinated Coffee on the Gut Microbiota and Depression-Like Behaviors of Sleep-Deprived Rats.
- Published in:
- Frontiers in Microbiology, 2022, v. 13, p. 1, doi. 10.3389/fmicb.2022.778512
- By:
- Publication type:
- Article
Identification of interferon-γ as a new molecular target of liver X receptor.
- Published in:
- Biochemical Journal, 2014, v. 459, n. 2, p. 345, doi. 10.1042/BJ20131442
- By:
- Publication type:
- Article
Tamoxifen inhibits macrophage FABP4 expression through the combined effects of the GR and PPAR? pathways.
- Published in:
- Biochemical Journal, 2013, v. 454, n. 3, p. 467, doi. 10.1042/BJ20130580
- By:
- Publication type:
- Article
Collateral Effects: The CRISPR‐Cas13a Gene‐Editing System Induces Collateral Cleavage of RNA in Glioma Cells (Adv. Sci. 20/2019).
- Published in:
- Advanced Science, 2019, v. 6, n. 20, p. N.PAG, doi. 10.1002/advs.201970124
- By:
- Publication type:
- Article
The CRISPR‐Cas13a Gene‐Editing System Induces Collateral Cleavage of RNA in Glioma Cells.
- Published in:
- Advanced Science, 2019, v. 6, n. 20, p. N.PAG, doi. 10.1002/advs.201901299
- By:
- Publication type:
- Article
Crispr Library Screening: Genome‐Wide CRISPR‐Cas9 Screening Identifies NF‐κB/E2F6 Responsible for EGFRvIII‐Associated Temozolomide Resistance in Glioblastoma (Adv. Sci. 17/2019).
- Published in:
- Advanced Science, 2019, v. 6, n. 17, p. N.PAG, doi. 10.1002/advs.201970103
- By:
- Publication type:
- Article
Genome‐Wide CRISPR‐Cas9 Screening Identifies NF‐κB/E2F6 Responsible for EGFRvIII‐Associated Temozolomide Resistance in Glioblastoma.
- Published in:
- Advanced Science, 2019, v. 6, n. 17, p. N.PAG, doi. 10.1002/advs.201900782
- By:
- Publication type:
- Article
EGFR‐vIII downregulated H2AZK4/7AC though the PI3K/AKT‐HDAC2 axis to regulate cell cycle progression.
- Published in:
- Clinical & Translational Medicine, 2020, v. 9, n. 1, p. 1, doi. 10.1186/s40169-020-0260-7
- By:
- Publication type:
- Article
EGFR-vIII downregulated H2AZK4/7AC though the PI3K/AKT-HDAC2 axis to regulate cell cycle progression.
- Published in:
- Clinical & Translational Medicine, 2020, v. 9, n. 1, p. 1, doi. 10.1186/s40169-020-0260-7
- By:
- Publication type:
- Article
EGFR‐vIII downregulated H2AZK4/7AC though the PI3K/AKT‐HDAC2 axis to regulate cell cycle progression.
- Published in:
- Clinical & Translational Medicine, 2020, v. 9, n. 1, p. 1, doi. 10.1186/s40169-020-0260-7
- By:
- Publication type:
- Article
Brain Mitochondrial Dysfunction: A Possible Mechanism Links Early Life Anxiety to Alzheimer’s Disease in Later Life.
- Published in:
- Aging & Disease, 2022, v. 13, n. 4, p. 1127, doi. 10.14336/AD.2022.0221
- By:
- Publication type:
- Article
Activation of liver X receptor inhibits the development of pulmonary carcinomas induced by 3-methylcholanthrene and butylated hydroxytoluene in BALB/c mice.
- Published in:
- Scientific Reports, 2016, p. 27295, doi. 10.1038/srep27295
- By:
- Publication type:
- Article
Expert opinion on translational research for advanced glioblastoma treatment.
- Published in:
- Cancer Biology & Medicine, 2023, v. 20, n. 5, p. 344, doi. 10.20892/j.issn.2095-3941.2023.0012
- By:
- Publication type:
- Article
Identification of the E2F1-RAD51AP1 axis as a key factor in MGMT-methylated GBM TMZ resistance.
- Published in:
- Cancer Biology & Medicine, 2023, v. 20, n. 5, p. 385, doi. 10.20892/j.issn.2095-3941.2023.0011
- By:
- Publication type:
- Article
TGFβ signaling-induced miRNA participates in autophagic regulation by targeting PRAS40 in mesenchymal subtype of glioblastoma.
- Published in:
- Cancer Biology & Medicine, 2020, v. 17, n. 3, p. 664, doi. 10.20892/j.issn.2095-3941.2019.0356
- By:
- Publication type:
- Article
Identification of potential targets of cinnamon for treatment against Alzheimer's disease-related GABAergic synaptic dysfunction using network pharmacology.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-24378-0
- By:
- Publication type:
- Article
Single-Cell Transcriptomics of Glioblastoma Reveals a Unique Tumor Microenvironment and Potential Immunotherapeutic Target Against Tumor-Associated Macrophage.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.710695
- By:
- Publication type:
- Article
CRISPR-Cas9 library screening combined with an exosome-targeted delivery system addresses tumorigenesis/TMZ resistance in the mesenchymal subtype of glioblastoma.
- Published in:
- Theranostics, 2024, v. 14, n. 7, p. 2835, doi. 10.7150/thno.92703
- By:
- Publication type:
- Article
Universal theranostic CRISPR/Cas13a RNA-editing system for glioma.
- Published in:
- Theranostics, 2023, v. 13, n. 15, p. 5305, doi. 10.7150/thno.84429
- By:
- Publication type:
- Article
TCA-phospholipid-glycolysis targeted triple therapy effectively suppresses ATP production and tumor growth in glioblastoma.
- Published in:
- Theranostics, 2022, v. 12, n. 16, p. 7032, doi. 10.7150/thno.74197
- By:
- Publication type:
- Article
PTRF/Cavin-1 enhances chemo-resistance and promotes temozolomide efflux through extracellular vesicles in glioblastoma.
- Published in:
- Theranostics, 2022, v. 12, n. 9, p. 4330, doi. 10.7150/thno.71763
- By:
- Publication type:
- Article
Neuronal STAT3/HIF-1α/PTRF axis-mediated bioenergetic disturbance exacerbates cerebral ischemia-reperfusion injury via PLA2G4A.
- Published in:
- Theranostics, 2022, v. 12, n. 7, p. 3196, doi. 10.7150/thno.71029
- By:
- Publication type:
- Article
Early administration of MPC-n(IVIg) selectively accumulates in ischemic areas to protect inflammation-induced brain damage from ischemic stroke.
- Published in:
- Theranostics, 2021, v. 11, n. 17, p. 8197, doi. 10.7150/thno.58947
- By:
- Publication type:
- Article
LncRNA PRADX-mediated recruitment of PRC2/DDX5 complex suppresses UBXN1 expression and activates NF-κB activity, promoting tumorigenesis.
- Published in:
- Theranostics, 2021, v. 11, n. 9, p. 4516, doi. 10.7150/thno.54549
- By:
- Publication type:
- Article
Rapid design and development of CRISPR-Cas13a targeting SARS-CoV-2 spike protein.
- Published in:
- Theranostics, 2021, v. 11, n. 2, p. 649, doi. 10.7150/thno.51479
- By:
- Publication type:
- Article
The Exosomal miR-1246 of Laryngeal Squamous Cell Carcinoma Induces Polarization of M2 Type Macrophages and Promotes the Invasiveness of Laryngeal Squamous Cell Carcinoma.
- Published in:
- Journal of Oncology, 2022, p. 1, doi. 10.1155/2022/4424221
- By:
- Publication type:
- Article
Urinary metabolomic changes and microbiotic alterations in presenilin1/2 conditional double knockout mice.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Dual‐Locking Nanoparticles Disrupt the PD‐1/PD‐L1 Pathway for Efficient Cancer Immunotherapy.
- Published in:
- Advanced Materials, 2019, v. 31, n. 51, p. N.PAG, doi. 10.1002/adma.201905751
- By:
- Publication type:
- Article
In Situ Modification of the Tumor Cell Surface with Immunomodulating Nanoparticles for Effective Suppression of Tumor Growth in Mice.
- Published in:
- Advanced Materials, 2019, v. 31, n. 32, p. N.PAG, doi. 10.1002/adma.201902542
- By:
- Publication type:
- Article
Brain Tumor Therapy: Systemic Delivery of Monoclonal Antibodies to the Central Nervous System for Brain Tumor Therapy (Adv. Mater. 19/2019).
- Published in:
- Advanced Materials, 2019, v. 31, n. 19, p. N.PAG, doi. 10.1002/adma.201970138
- By:
- Publication type:
- Article
Systemic Delivery of Monoclonal Antibodies to the Central Nervous System for Brain Tumor Therapy.
- Published in:
- Advanced Materials, 2019, v. 31, n. 19, p. N.PAG, doi. 10.1002/adma.201805697
- By:
- Publication type:
- Article
PTRF/Cavin-1 as a Novel RNA-Binding Protein Expedites the NF-κB/PD-L1 Axis by Stabilizing lncRNA NEAT1, Contributing to Tumorigenesis and Immune Evasion in Glioblastoma.
- Published in:
- Frontiers in Immunology, 2022, v. 12, p. 1, doi. 10.3389/fimmu.2021.802795
- By:
- Publication type:
- Article
Editorial: The State-of-Art in Immuno-Oncology, What to Do With Glioblastoma?
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.788733
- By:
- Publication type:
- Article
Putting Proteomics Into Immunotherapy for Glioblastoma.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2021.593255
- By:
- Publication type:
- Article
HIF1α/ATF3 partake in PGK1 K191/K192 succinylation by modulating P4HA1/succinate signaling in glioblastoma.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 8, p. 1405, doi. 10.1093/neuonc/noae040
- By:
- Publication type:
- Article
EPIC-1042 as a potent PTRF/Cavin1–caveolin-1 interaction inhibitor to induce PARP1 autophagic degradation and suppress temozolomide efflux for glioblastoma.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 1, p. 100, doi. 10.1093/neuonc/noad159
- By:
- Publication type:
- Article
EPIC-0307-mediated selective disruption of PRADX–EZH2 interaction and enhancement of temozolomide sensitivity to glioblastoma via inhibiting DNA repair and MGMT.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 11, p. 1976, doi. 10.1093/neuonc/noad102
- By:
- Publication type:
- Article
A novel compound EPIC-0412 reverses temozolomide resistance via inhibiting DNA repair/MGMT in glioblastoma.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 5, p. 857, doi. 10.1093/neuonc/noac242
- By:
- Publication type:
- Article
Blood exosomes-based targeted delivery of cPLA2 siRNA and metformin to modulate glioblastoma energy metabolism for tailoring personalized therapy.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 11, p. 1871, doi. 10.1093/neuonc/noac071
- By:
- Publication type:
- Article
PTRF/cavin-1 remodels phospholipid metabolism to promote tumor proliferation and suppress immune responses in glioblastoma by stabilizing cPLA2.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 3, p. 387, doi. 10.1093/neuonc/noaa255
- By:
- Publication type:
- Article
EXTH-08. MESENCHYMAL GLIOBLASTOMA CONSTITUTES A MAJOR ceRNA SIGNATURE IN THE TGF-PATHWAY.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi86, doi. 10.1093/neuonc/noy148.357
- By:
- Publication type:
- Article
Inhibition of tumor growth by U0126 is associated with induction of interferon-γ production.
- Published in:
- International Journal of Cancer, 2015, v. 136, n. 4, p. 771, doi. 10.1002/ijc.29038
- By:
- Publication type:
- Article
Silencing MR-1 Protects against Myocardial Injury Induced by Chronic Intermittent Hypoxia by Targeting Nrf2 through Antioxidant Stress and Anti-Inflammation Pathways.
- Published in:
- Journal of Healthcare Engineering, 2022, p. 1, doi. 10.1155/2022/3471447
- By:
- Publication type:
- Article